Literature DB >> 8782046

Unusual molecular findings in autosomal recessive spinal muscular atrophy.

G Matthijs1, E Schollen, E Legius, K Devriendt, N Goemans, H Kayserili, M Y Apäk, J J Cassiman.   

Abstract

All three types of autosomal recessive spinal muscular atrophy map to chromosome 5q11.2-q13.3 and are associated with deletions or mutations of the SMN (survival motor neurone) gene. The availability of a test to distinguish between the SMN gene and its nearly identical centromeric copy cBCD541 allows molecular diagnosis. We have analysed patients from 24 Belgian and 34 Turkish families for the presence or absence of a deletion in the SMN gene. A homozygous deletion in the SMN gene was seen in 90% of unrelated SMA patients. A non-radioactive SSCP assay allows for a semiquantitative analysis of the copy number of the centromeric and SMN genes. Hence, direct carrier detection has become feasible under certain conditions. We observed a phenotypically normal male, father of an SMA type I patient, presenting with only a single copy of the SMN gene and lacking both copies of the cBCD541 gene. This illustrates that a reduction of the total number of SMN and cBCD541 genes to a single SMN copy is compatible with normal life. In another SMA type I family, there is evidence for a de novo deletion of the centromeric gene in a normal sib. This observation illustrates the susceptibility of the SMA locus to de novo deletions and rearrangements.

Entities:  

Mesh:

Year:  1996        PMID: 8782046      PMCID: PMC1050632          DOI: 10.1136/jmg.33.6.469

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  Prenatal diagnosis of spinal muscular atrophy by gene deletion analysis.

Authors:  N R Rodrigues; L Campbell; N Owen; C H Rodeck; K E Davies
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

2.  SMN gene deletion in variant of infantile spinal muscular atrophy.

Authors:  L Bürglen; R Spiegel; J Ignatius; J M Cobben; P Landrieu; S Lefebvre; A Munnich; J Melki
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

3.  Refinement of the spinal muscular atrophy locus to the interval between D5S435 and MAP1B.

Authors:  V M Soares; L M Brzustowicz; P W Kleyn; J A Knowles; D A Palmer; S Asokan; G K Penchaszadeh; T L Munsat; T C Gilliam
Journal:  Genomics       Date:  1993-02       Impact factor: 5.736

4.  Use of genetic and physical mapping to locate the spinal muscular atrophy locus between two new highly polymorphic DNA markers.

Authors:  O Clermont; P Burlet; L Burglen; S Lefebvre; F Pascal; J McPherson; J J Wasmuth; D Cohen; D Le Paslier; J Weissenbach
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

5.  A hungarian study on Werdnig-Hoffmann disease.

Authors:  A Czeizel; J Hamula
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

6.  Mapping of human microtubule-associated protein 1B in proximity to the spinal muscular atrophy locus at 5q13.

Authors:  L L Lien; F M Boyce; P Kleyn; L M Brzustowicz; J Menninger; D C Ward; T C Gilliam; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

7.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

8.  The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.

Authors:  N Roy; M S Mahadevan; M McLean; G Shutler; Z Yaraghi; R Farahani; S Baird; A Besner-Johnston; C Lefebvre; X Kang
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

9.  Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy.

Authors:  N R Rodrigues; N Owen; K Talbot; J Ignatius; V Dubowitz; K E Davies
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

  9 in total
  8 in total

Review 1.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family.

Authors:  L Campbell; R J Daniels; V Dubowitz; K E Davies
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 3.  When is a deletion not a deletion? When it is converted.

Authors:  A H Burghes
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

4.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype.

Authors:  L Campbell; A Potter; J Ignatius; V Dubowitz; K Davies
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

Review 6.  Spinal muscular atrophy: untangling the knot?

Authors:  I Biros; S Forrest
Journal:  J Med Genet       Date:  1999-01       Impact factor: 6.318

7.  Functional Segments on Intrinsically Disordered Regions in Disease-Related Proteins.

Authors:  Hiroto Anbo; Masaya Sato; Atsushi Okoshi; Satoshi Fukuchi
Journal:  Biomolecules       Date:  2019-03-05

8.  The Birth Prevalence of Spinal Muscular Atrophy: A Population Specific Approach in Estonia.

Authors:  Siiri Sarv; Tiina Kahre; Eve Vaidla; Sander Pajusalu; Kai Muru; Haide Põder; Katrin Gross-Paju; Sandra Ütt; Riina Žordania; Inga Talvik; Eve Õiglane-Shlik; Kristina Muhu; Katrin Õunap
Journal:  Front Genet       Date:  2021-12-22       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.